Clinical Trial Update: Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating tapentadol hydrochloride in severe chronic low back pain patients with tolerability issues on WHO Step III analgesics; study terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Pain

Drugs mentioned

• Tapentadol hydrochloride (Tapentadol hydrochloride)

Snippet

Sponsor: Grünenthal GmbH | Conditions: Pain, Chronic Pain | Phase 3 | Status: TERMINATED | Results posted: 2013-03-18